ACAmy Chadburn

Amy Chadburn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amy Chadburn has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Amy Ann Lo

    Genentech Inc., South San Francisco, California

    1 shared publication
  • Anmaar M. Abdul-Nabi

    From the Department of Pathology, Northwestern University-Feinberg School of Medicine, Chicago, Illinois (Drs Chadburn, Abdul-Nabi, Teruya, and Lo)

    1 shared publication
  • Bryan Scott Teruya

    From the Department of Pathology, Northwestern University-Feinberg School of Medicine, Chicago, Illinois (Drs Chadburn, Abdul-Nabi, Teruya, and Lo)

    1 shared publication
  • Jules A. Cohen

    Department of Hematology and Medical Oncology, Weill Cornell Medical College, New York, USA

    1 shared publication
  • Nicole C. Panarelli

    Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, USA

    1 shared publication
  • Rebecca Elstrom

    Department of Hematology and Medical Oncology, Weill Cornell Medical College, New York, USA

    1 shared publication

Latest Publications

  • Lymphoid Proliferations Associated With Human Immunodeficiency Virus Infection

    by Amy Chadburn, Anmaar M. Abdul-Nabi, Bryan Scott Teruya, Amy A. Lo

    Context.— Individuals who are immune deficient are at an increased risk for developing lymphoproliferative lesions and lymphomas. Human immunodeficiency virus (HIV) infection is 1 of 4 clinical settings associated with immunodeficiency recognized by the World Health Organization (WHO) in which there is an increased incidence of lymphoma and other lymphoproliferative disorders. Objectives.— To describe the major categories of benign lymphoid proliferations, including progressive HIV-related lymphadenopathy, benign lymphoepithelial cystic lesions, and multicentric Castleman disease, as well as the different types of HIV-related lymphomas as defined by the WHO. The characteristic morphologic, immunophenotypic, and genetic features of the different entities will be discussed in addition to some of the pathogenetic mechanisms. Data Sources.— The WHO classification of tumors of hematopoietic and lymphoid tissues (2001 and 2008), published literature from PubMed (National Library of Medicine), published textbooks, and primary material from the authors' current and previous institutions. Conclusions.— HIV infection represents one of the clinical settings recognized by the WHO in which immunodeficiency-related lymphoproliferative disorders may arise. Although most lymphomas that arise in patients with HIV infection are diffuse, aggressive B-cell lesions, other lesions, which are “benign” lymphoid proliferations, may also be associated with significant clinical consequences. These lymphoproliferations, like many other immunodeficiency-associated lymphoproliferative disorders, are often difficult to classify. Studies of HIV-associated lymphoid proliferations will continue to increase our understanding of both the immune system and lymphomagenesis.


  • NK/T cell non-Hodgkin lymphoma in a HIV-positive patient

    by Nicole C. Panarelli, Richard R. Furman, Y. Lynn Wang, Rebecca Elstrom, Jules A. Cohen, Amy Chadburn

    NK/T lymphomas have rarely been reported in HIV/AIDS patients. Here we report a case of a 37-year-old woman, with AIDS and a recent diagnosis of Kaposi sarcoma in a mesenteric lymph node, who presented with extra-ocular nerve palsies and gastrointestinal bleeding. A small intestine resection specimen revealed an extra-nodal NK/T cell lymphoma, nasal type. The unique presentation of this rare and aggressive lymphoma in the setting of AIDS and Kaposi sarcoma underscores the importance of maintaining a broad differential diagnosis when evaluating a malignant neoplasm from a HIV-positive patient.